(Q46566287)

English

Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro

scientific article published in July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Francisco J Diaz-Corrales

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

author name string

Masato Asanuma

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

Ikuko Miyazaki

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

Masako Shimizu

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

Ken-ichi Tanaka

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

Norio Ogawa

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

publication date

1 July 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

Neurological Research

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

27

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

533-539

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection.

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Repeated L-dopa administration reduces the ability of dopamine storage and abolishes the supersensitivity of dopamine receptors in the striatum of intact rat.

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Intraneuronal dopamine-quinone synthesis: A review

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Potential oxidative pathways of brain catecholamines

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Overexpression of Cu-Zn superoxide dismutase protects neuroblastoma cells against dopamine cytotoxicity accompanied by increase in their glutathione level

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist.

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Neuroprotective effects of pramipexole in young and aged MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Pharmacological approaches to counter the toxicity of Dopa.

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Randomized, double‐blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Slowing Parkinson's disease progression: recent dopamine agonist trials

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function

1 reference

https://api.crossref.org/works/10.1179%2F016164105X22093

21 January 2018

Identifiers

10.1179/016164105X22093

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/15978181

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46566287&oldid=2118506538"